Cancer Treatment Centers of America, Philadelphia — Philadelphia, Pennsylvania

Cancer Treatment Centers of America, Philadelphia is a clinical research site located in Philadelphia, Pennsylvania, United States 19124.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Cancer Treatment Centers of America, Philadelphia has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Treatment Centers of America, Philadelphia?

Cancer Treatment Centers of America, Philadelphia has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Treatment Centers of America, Philadelphia conducted?

Cancer Treatment Centers of America, Philadelphia has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer.

Is Cancer Treatment Centers of America, Philadelphia accredited by Crixeo Health?

Cancer Treatment Centers of America, Philadelphia has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Treatment Centers of America, Philadelphia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.